The Washington, DC Health Impact Forum

United for impact: a multi-sector collaboration to transform health and ThE life sciences

WASHINGTON, DC | may 7-9, 2017

HOSTED AT The willard intercontinental, and the ronald reagan building and international trade center

co-hosted with the virginia biotechnology association

and special participation by the cavendish impact foundation

By Invitation Only

Next month, Cavendish Global will host its first Health Impact Forum in Washington, DC. Joining together with the Virginia Biotechnology Association (VirginiaBio) and its distinguished network, Cavendish Global will welcome members to the historic Willard InterContinental, and Ronald Reagan Building and International Trade Center, for three days of insightful industry discussions, groundbreaking discoveries and innovations, exclusive networking opportunities and Cavendish's unique social events — designed to share ideas, develop relationships, and accelerate transformational innovation and impact.

 
 

Featured Speakers

Please check back often for an updated list of speakers

Forum Schedule

Please check back as the schedule is updated daily

 

SUNDAY, may 7  |  willard intercontinental

CAVENDISH ADVISORS PROGRAM and rehearsals

8:00 AM - 12:00 PM  |  Innovation Partner Rehearsals  |  Contact Member Services for Reservations

1:00 PM - 5:30 PM  |  Cavendish Advisors Program  |  Hosted by Jonathan Sackier, MD

Full schedule for the Washington, DC Cavendish Advisors Program to be released shortly.

6:00 - 10:00 PM  |  Cocktails and Dinner at the Crystal Room, Willard InterContinental

 

monday, may 8  |  ronald reagan building and international trade center

HEALTH IMPACT FORUM — Pavilion and horizon rooms

8:15 - 8:30 AM  |  Welcome to the Washington, DC Forum  |  J. Michael Moffat, Chairman, Cavendish Global

8:30 - 9:15 AM  |  Keynote: The Rise of Impact Investing — Perspectives from a Reagan White House Official  |  The Honorable James Rosebush, CEO, GrowthStrategy

9:15 - 10:15 AM  |  Groundbreaking Discoveries and Innovations

10:15 - 11:00 AM  |  Partnering Meetings and Coffee Break

11:00 - 11:15 AM  |  Introducing Cavendish Impact Capital

11:15 - 12:00 PM  |  DARPA and its Investments in Medicine Manufacturing  |  Tyler McQuade, PhD, Deputy Director, Defense Sciences Office, DARPA

12:00 - 12:45 PM  |  The Emerging Rare Disease Landscape and its Future in Medical Innovation  |  Marshall L. Summar, MD, Director, Rare Disease Institute, Children's National Medical Center

12:45 - 1:45 PM  |  Lunch  |  Horizon Room at the Ronald Reagan Building

1:45 - 2:30 PM  |  The Neuroscience of Addiction  |  Michael Grisham, CEO, The Catalyst (VBHRC); Michael J. Friedlander, PhD, Executive Director, Virginia Tech Carilion Research Institute; F. Gerard Moeller, MD, Director, Drug and Alcohol Studies, Virginia Commonwealth University; and Warren Bickel, PhD, Director, Addiction Recovery Research Center, Virginia Tech

2:30 - 3:30 PM  |  Groundbreaking Discoveries and Innovations

3:30 - 4:15 PM  |  Partnering Meetings and Coffee Break

4:15 - 5:00 PM  |  Investing to Propel Innovation: The Purposeful and Strategic Development of a Patient-Driven Foundation  |  Alexandra Reeve Givens, Board Member, Christopher and Dana Reeve Foundation

5:30 - 7:00 PM  |  Cocktail Reception  |  Offices of Morgan, Lewis & Bockius LLP — 1111 Pennsylvania Ave NW

 

tuesday, may 9  |  ronald reagan building and international trade center

HEALTH IMPACT FORUM — Pavilion and horizon rooms

8:00 - 8:15 AM  |  Welcome  |  Jonathan Sackier, MD, Chief Medical Officer, Cavendish Global

8:15 - 9:00 AM  |  Keynote  |  To Be Announced

9:00 - 9:45 AM  |  The Promise of Precision Medicine Diagnostics: In-Vivo, In-Vitro, In-Silico  |  Tom Miller, Founder and Managing Partner, GreyBird Ventures

9:45 - 10:45 AM  |  Groundbreaking Discoveries and Innovations

10:45 - 11:30 AM  |  Partnering Meetings and Coffee Break

11:30 - 12:15 PM  |  Keynote  |  Richard P. Shannon, MD, Executive Vice President for Health Affairs, University of Virginia

12:15 - 12:45 PM  |  Interview: Accelerating the Future for Foster Kids  |  Peter Samuelson, First Star

12:45 - 1:45 PM  |  Lunch  |  Horizon Room at the Ronald Reagan Building

1:45 - 2:30 PM  |  Panel: Investing in Rare Disease: Making the Financial Models Work  | Laura S. Thrall, President and CEO of CureSearch; panelists to be announced

2:30 - 3:30 PM  |  Groundbreaking Discoveries and Innovations

3:30 - 4:15 PM  |  Partnering Meetings and Coffee Break

4:15 - 5:00 PM  |  The Ice Bucket Challenge and the Outcomes for ALS Research  |  Barbara Newhouse, President and CEO, The ALS Association

5:00 - 6:30 PM  |  Closing Cocktail Reception and Awards Ceremony